Northwire Canada EditionSaturday, October 17, 2026
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%

Healthcare

Page 79
  1. Jan 02, 2026 · 09:01 · OTC

    Ocumetics Technology Announces Closing of First Tranche of Brokered LIFE Offering Led by Centurion One Capital

    Ocumetics Technology Announces Closing of First Tranche of Brokered LIFE Offering Led by Centurion One Capital

    01
  2. Jan 02, 2026 · 08:01 · PHRM

    PharmaTher CEO Publishes Letter to Shareholders

    PharmaTher CEO Publishes Letter to Shareholders

    02
  3. Dec 31, 2025 · 20:45 · XRTX

    XORTX makes board changes

    XORTX makes board changes

    03
  4. Dec 31, 2025 · 20:04 · VIVI

    Tempramed expands distribution partnership in S. Korea

    Tempramed expands distribution partnership in S. Korea

    04
  5. Dec 31, 2025 · 18:15 · XRTX

    XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update

    XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update

    05
  6. Dec 31, 2025 · 18:13 · HEM

    Hemostemix closes $480,000 financing

    Hemostemix closes $480,000 financing

    06
  7. Dec 31, 2025 · 17:02 · VIVI

    TempraMed Deepens Asian Market Penetration with Expanded Distribution Partnership and Meaningful Commercial Order in South Korea

    TempraMed Deepens Asian Market Penetration with Expanded Distribution Partnership and Meaningful Commercial Order in South Korea

    07
  8. Dec 31, 2025 · 16:01 · AGN

    Algernon Announces Additional Increase to Private Placement Financing to $858,000 and Final Closing of the Financing

    Algernon Announces Additional Increase to Private Placement Financing to $858,000 and Final Closing of the Financing

    08
  9. Dec 31, 2025 · 15:13 · NURS

    Hydreight to distribute HSC's at-home STI testing kits

    Hydreight to distribute HSC's at-home STI testing kits

    09
  10. Dec 31, 2025 · 14:39 · HEM

    Hemostemix Closes $480,000 Private Placement at $0.12 per Share

    Hemostemix Closes $480,000 Private Placement at $0.12 per Share

    10
  11. Dec 31, 2025 · 08:31 · BUX

    BioMark: 2025 Achievements & 2026 Vision

    BioMark: 2025 Achievements & 2026 Vision

    11
  12. Dec 31, 2025 · 08:00 · BIOV

    2025 Corporate Review

    2025 Corporate Review

    12
  13. Dec 31, 2025 · 08:00 · NURS

    Hydreight Technologies Enters the At-Home STI Testing Market With Exclusive Distribution and 50,000 Pre-Orders

    Hydreight Technologies Enters the At-Home STI Testing Market With Exclusive Distribution and 50,000 Pre-Orders

    13
  14. Dec 30, 2025 · 20:00 · MIR

    MedMira Reports First Quarter Results FY2026

    MedMira Reports First Quarter Results FY2026

    14
← Newer Older →